Skip to content

Capricor Therapeutics CAPR Market capitalization

Market capitalization at other companies

Pfizer logo
PfizerPFE
$159.73B+11.1%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$2.28B-63.1%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$5.64B+40.3%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$2.11B+75.2%
Vericel logo
VericelVCEL
$1.64B-26.8%
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
$2.99B+153%

Other financials

Income statement

See full
Revenue--100%
Operating income-$36.8M-47.2%
Net income-$33.9M-39.2%
EPS (diluted)-$0.59-11.3%

Balance sheet

See full
Cash & equivalents$105.4M+266%
Total debt$14.8M+1,083%
Total equity$278.7M+118%
Total assets$326.3M+112%

Cash flow

See full
Operating cash flow-$29.3M-355%
CapEx$5.1M+472%
Free cash flow-$34.4M-369%

Valuation

See full
Enterprise value$1.62B+308%

Profitability

See full
Operating margin-778.8%-1,038pp
Net margin-736.6%-981pp
FCF margin-563.9%-954pp

Returns & leverage

See full
Return on equity-56.4%-11.3pp
Debt / equity0.1×0.0×
Current ratio8.4×+1.9×

Where this comes from

Computed from the period-end share price: $1.75B.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Capricor Therapeutics's market capitalization?
Capricor Therapeutics (CAPR) reported market capitalization of $1.75B in Q1 2026.
How has Capricor Therapeutics's market capitalization changed year-over-year?
Capricor Therapeutics's market capitalization increased by 303.3% year-over-year, from $433.47M to $1.75B.
What is the long-term trend for Capricor Therapeutics's market capitalization?
Over 5 years (2020 to 2025), Capricor Therapeutics's market capitalization has grown at a 80.1% compound annual growth rate (CAGR), from $82.83M to $1.57B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.